Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 4:11 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | RA CAPITAL MANAGEMENT L.P. | 1,136,000 3.9% | -612,021 (-35.01%) | View |
| 2022-02-14 1:02 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 3,027,672 9.99% | 1,308,056 (+76.07%) | View |
| 2022-02-14 06:39 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Bain Capital Life Sciences Fund L.P. | 2,886,542 11% | 1,238,057 (+75.10%) | View |
| 2022-02-11 5:08 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 1,836,349 6.4% | 356 (+0.02%) | View |
| 2022-02-11 3:17 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | HIRSCHMAN ORIN | 1,531,600 6.2% | 72,700 (+4.98%) | View |
| 2022-01-19 11:05 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Lincoln Park Capital Fund LLC | 1,810,087 6.44% | 1,810,087 (New Position) | View |
| 2021-11-17 5:27 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Point72 Asset Management L.P. | 1,500,243 5.6% | 1,500,243 (New Position) | View |
| 2021-06-28 7:32 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | HIRSCHMAN ORIN | 1,458,900 6.2% | 1,458,900 (New Position) | View |
| 2021-05-07 5:09 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | BlackRock Inc. BLK | 1,074,491 4.5% | 40,988 (+3.97%) | View |
| 2021-04-08 09:02 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 2,624,988 11.1% | 1,798,564 (+217.63%) | View |
| 2021-03-25 4:15 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 1,835,993 7.6% | 587,000 (+47.00%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | RA CAPITAL MANAGEMENT L.P. | 1,748,021 9.9% | 99,536 (+6.04%) | View |
| 2021-02-16 08:55 am Sale | 13G | X4 PHARMACEUTICALS INC XFOR | SPHERA FUNDS MANAGEMENT LTD. | 250,000 1.51% | -720,000 (-74.23%) | View |
| 2021-02-12 8:57 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 1,719,616 9.99% | 59,141 (+3.56%) | View |
| 2021-02-12 5:33 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | EcoR1 Capital LLC | 600,000 3.6% | -415,400 (-40.91%) | View |
| 2021-02-12 12:39 pm Sale | 13G | X4 PHARMACEUTICALS INC XFOR | Flynn James E | 457,500 2.73% | -449,437 (-49.56%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | BlackRock Inc. BLK | 1,033,503 6.3% | 1,033,503 (New Position) | View |
| 2020-12-30 5:26 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital LLC | 826,424 5.1% | 826,424 (New Position) | View |
| 2020-09-10 10:03 am Sale | 13G | X4 PHARMACEUTICALS INC XFOR | FMR LLC | 817,300 4.915% | -532,700 (-39.46%) | View |
| 2020-02-14 5:06 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 1,660,475 9.99% | 368,059 (+28.48%) | View |